Another look at amphetamine-induced stereotyped locomotor activity in rats using a new statistic to measure locomotor stereotypy.

Rat open field behavior is often used as a tool to study the behavioral effects of drugs. In this report, drug-induced patterns of locomotion in an open field were studied with the aid of a simple new statistic. Briefly, the animal's path through the open field is converted into a series of trips. Gamma (gamma) estimates the probability that the animal will repeat the trip that it has just exhibited; thus gamma quantifies "locomotor stereotypy". Trip lengths can also be compared across drug groups. Thus caffeine has no effect on gamma even though it produces a dose-related increase in locomotions. Caffeine does not produce amphetamine-like stereotypy. On the other hand, amphetamine produces a dose-related increase in gamma. Although gamma was designed to detect any pattern of locomotor behavior, rats treated with high doses of amphetamine almost always exhibited the same pattern of locomotor behavior - repetitive trips around the perimeter of the open field. Although further characterization of the statistic is necessary, these findings suggest that gamma has potential for quantifying "locomotor stereotypy" and for providing a more subtle description of locomotor behavior in general.

Patterns of locomotor and stereotypic behavior during continuous amphetamine administration in rats.

The present study examined the behavioral effects of continuous subcutaneous infusion of amphetamine (AMPH) to rats. Saline and 3 AMPH doses were infused for 96 hr (0.2 mg/kg/hr, 0.55 mg/kg/hr, 0.9 mg/kg/hr; n = 12). Locomotor behavior, grooming, gnawing and licking, sniffing, and head-bobbing were recorded for each animal for 1 hr in the light cycle and 1 hr in the dark cycle. The low dose AMPH animals exhibited increased locomotor activity. The medium and high dose groups developed similar behavioral patterns consisting of increased grooming and sniffing and changes in circadian rhythms of activity. Although most behaviors exhibited were similar to those discussed in previous literature describing the effects of chronic amphetamine, the pattern of the behaviors was not. Furthermore, continuous administration of AMPH seems to reliably increase the frequency of behaviors which are rarely observed after acute or chronic amphetamine. This finding has important implications since administration of AMPH to rats has been suggested to be an animal model of schizophrenia.

Behavioral effects of pergolide mesylate on food intake and body weight.

In a crossover design experiment, pergolide mesylate significantly suppressed food intake and body weight in spayed female rats. Inhibition of food intake by a constant dose of pergolide progressively diminished with repeated administrations. Pergolide continued to suppress body weight with no indications of tolerance. When pergolide was discontinued, body weight increased sufficiently to compensate for the loss and failure to gain during drug treatment. A second experiment investigated the observation that animals injected first with vehicle showed greater anorexia when subsequently injected with pergolide than did animals injected first with pergolide. In addition, tolerance was further assessed by administering on two occasions a higher dose of pergolide. Following chronic pergolide treatment, this dose was insufficient to reinstate anorexia; however, after a period of abstinence, this dose produced anorexia comparable to that observed at the beginning of pergolide treatment. Due to pergolide mesylate's action as a postsynaptic dopamine agonist, a dopaminergic neural system is implicated in pergolide induced anorexia.

VMN lesion deficits in lordosis: partial reversal with pergolide mesylate.

Bilateral lesions of the VMN virtually eliminate estrogen-progesterone stimulated lordosis in the spayed female rat. The present paper demonstrates that some recovery in lordosis is possible following treatment with pergolide mesylate, a potent long acting dopamine agonist. Chronic administration of pergolide mesylate in combination with estrogen and progesterone resulted in significant recovery of lordosis in VMN lesioned female rats. The magnitude of recovery was related to the duration and/or dose of pergolide.

Permanent deficits in lordosis behavior in female rats with lesions of the ventromedial nucleus of the hypothalamus.

Bilateral lesions of the ventromedial nucleus of the hypothalamus (VMN) significantly attentuated lordosis behavior in the female rat. The degree of this deficit was significantly correlated with the amount of damage to the VMN. There was no improvement in lordosis performance even after an extended recovery period.